BACKGROUND: Databases of suspected adverse drug reactions (ADRs) are a cornerstone of pharmacovigilance. With increasing numbers of reports, additional statistical approaches are needed to better use the data. AIM: The present study was aimed at elucidating the European Medicines Agency's (EMA) use of a novel 'paediatric' query to analyse the data in its ADR database 'EudraVigilance'. METHODS: The proportional reporting ratio (PRR) is a measure of disproportionality for which the underlying principle is that a drug-event pair of interest is reported more often than expected relative to an independence model. The EMA's paediatric query, based on PRRs, was applied to the data in EudraVigilance to investigate the extent to which the known association between enalapril and renal toxicity was reflected in reported ADRs comparing children with adults and with adjustment for the effect of multiplicity. RESULTS: The comparison of PRRs for children (14.91, 95% confidence interval [CI] 13.05-17.04) versus adults (2.66, 95% CI 2.52-2.82) confirmed a higher risk of renal ADRs with enalapril when used in children compared with all other medicines and compared with adults. CONCLUSIONS: The EMA's paediatric query can be used to highlight an imbalance for a drug-event pair among ADRs for a medicine when used in children and as compared with adults. Applying the query in practice can help the EMA to decide on whether stand-alone paediatric medicine development is warranted, and which, if any, further studies are necessary. Ongoing evaluation of the query is contributing to the development of new methods and guidance.
BACKGROUND: Databases of suspected adverse drug reactions (ADRs) are a cornerstone of pharmacovigilance. With increasing numbers of reports, additional statistical approaches are needed to better use the data. AIM: The present study was aimed at elucidating the European Medicines Agency's (EMA) use of a novel 'paediatric' query to analyse the data in its ADR database 'EudraVigilance'. METHODS: The proportional reporting ratio (PRR) is a measure of disproportionality for which the underlying principle is that a drug-event pair of interest is reported more often than expected relative to an independence model. The EMA's paediatric query, based on PRRs, was applied to the data in EudraVigilance to investigate the extent to which the known association between enalapril and renal toxicity was reflected in reported ADRs comparing children with adults and with adjustment for the effect of multiplicity. RESULTS: The comparison of PRRs for children (14.91, 95% confidence interval [CI] 13.05-17.04) versus adults (2.66, 95% CI 2.52-2.82) confirmed a higher risk of renal ADRs with enalapril when used in children compared with all other medicines and compared with adults. CONCLUSIONS: The EMA's paediatric query can be used to highlight an imbalance for a drug-event pair among ADRs for a medicine when used in children and as compared with adults. Applying the query in practice can help the EMA to decide on whether stand-alone paediatric medicine development is warranted, and which, if any, further studies are necessary. Ongoing evaluation of the query is contributing to the development of new methods and guidance.
Authors: Empar Lurbe; Renata Cifkova; J Kennedy Cruickshank; Michael J Dillon; Isabel Ferreira; Cecilia Invitti; Tatiana Kuznetsova; Stephane Laurent; Giuseppe Mancia; Francisco Morales-Olivas; Wolfgang Rascher; Josep Redon; Franz Schaefer; Tomas Seeman; George Stergiou; Elke Wühl; Alberto Zanchetti Journal: J Hypertens Date: 2009-09 Impact factor: 4.844
Authors: P Friberg; B Sundelin; S O Bohman; A Bobik; H Nilsson; A Wickman; H Gustafsson; J Petersen; M A Adams Journal: Kidney Int Date: 1994-02 Impact factor: 10.612
Authors: Katherine A Lindle; Kim Dinh; Brady S Moffett; W Buck Kyle; Natalie M Montgomery; Susan D Denfield; Jarrod D Knudson Journal: Pediatr Cardiol Date: 2014-03 Impact factor: 1.655
Authors: Xiaomei I Liu; Paul Schuette; Gilbert J Burckart; Dionna J Green; Julie La; Janelle M Burnham; Natella Rakhmanina; Adelaide Robb; Shiew Mei Huang; John N van den Anker Journal: J Pediatr Date: 2019-01-21 Impact factor: 4.406
Authors: Anthony J Garcia-Prats; Nicole Salazar-Austin; James H Conway; Kendra Radtke; Sylvia M LaCourse; Elizabeth Maleche-Obimbo; Anneke C Hesseling; Rada M Savic; Sharon Nachman Journal: Clin Infect Dis Date: 2021-03-15 Impact factor: 9.079
Authors: Kristina Star; Lovisa Sandberg; Tomas Bergvall; Imti Choonara; Pia Caduff-Janosa; I Ralph Edwards Journal: Pharmacoepidemiol Drug Saf Date: 2019-02-15 Impact factor: 2.890
Authors: Esmé J Baan; Veronique A de Smet; Christina E Hoeve; Alexandra C Pacurariu; Miriam C J M Sturkenboom; Johan C de Jongste; Hettie M Janssens; Katia M C Verhamme Journal: Drug Saf Date: 2020-01 Impact factor: 5.606